Distribution and Activity of Lenvatinib in Brain Tumor Models of Human Anaplastic Thyroid Cancer Cells in Severe Combined Immune Deficient Mice

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-18-0695
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Treatment With Lenvatinib to Anaplastic Thyroid Cancer :

JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
2018English

Administration of Lenvatinib to Patients With Anaplastic Thyroid Cancer

JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
2018English

Lenvatinib vs. Palliative Therapy for Stage IVC Anaplastic Thyroid Cancer

Molecular and Clinical Oncology
Cancer ResearchOncology
2019English

Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle Aspiration

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2018English

Lenvatinib as a Novel Treatment for Anaplastic Thyroid Cancer: A Retrospective Study

Oncology Letters
Cancer ResearchOncology
2018English

Biochemical Effects of Combined Action of ?-Irradiation and Paclitaxel on Anaplastic Thyroid Cancer Cells

Ukrainian Biochemical Journal
Biochemistry
2013English

Methylglyoxal Acts as a Tumor-Promoting Factor in Anaplastic Thyroid Cancer

Cells
2019English

Antitumor Activity of Fucoidan in Anaplastic Thyroid Cancer via Apoptosis and Anti-Angiogenesis

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2017English

Molecular Mechanisms of Paclitaxel and NM-3 on Human Gastric Cancer in a Severe Combined Immune Deficiency Mice Orthotopic Implantation Model

World Journal of Gastroenterology
MedicineGastroenterology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy